Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: A double-blind, randomized, cross-over, placebo-controlled study

Cephalalgia

Volumn 26, Issue 7, 2006, Pages 871-874

  Krymchantowski, A V ^a,b,c,g   Filho, P F M ^f   Bigal, M E ^d,e  

^a Instituto de Neurologia Deolindo Couto   (Brazil)

^b Hospital Pasteur   (Brazil)

^c Headache Center of Rio   (Brazil)

^d NEW ENGLAND CENTER FOR HEADACHE   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^g NONE   (Brazil)

Author keywords

Acute treatment; Migraine; Rizatriptan; Trimebutine

Indexed keywords

PLACEBO; RIZATRIPTAN; TRIMEBUTINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIGRAINE; NAUSEA; PAIN; PHOTOPHOBIA; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SOMNOLENCE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; DRUG COMBINATIONS; FEMALE; GASTROINTESTINAL AGENTS; GASTROPARESIS; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NAUSEA; PLACEBO EFFECT; SEROTONIN AGONISTS; TREATMENT OUTCOME; TRIAZOLES; TRIMEBUTINE; TRYPTAMINES;

EID: 33745059593     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2006.01136.x     Document Type: Article

References (30)

1. Stewart WF Schechter A Lipton RB. Migraine heterogeneity, disability, pain intensity and attack frequency and duration. Neurology 1994 44 ( Suppl. 4 S24 S39.
2. Rasmussen BK. Epidemiology of headache. Cephalalgia 1995 15 : 45 68.
3. Stewart WF Lipton RB Simon D. Work-related disability: results from the American migraine study. Cephalalgia 1996 16 : 231 8.
4. Tfelt-Hansen P Lipton RB. Prioritizing treatment. In : Olesen J Tfelt-Hansen P Welch KMA, editors. The headaches. New York : Raven Press 1993 : 359 62.
5. Ferrari MD Roon KI Lipton RB Goadsby PJ. Oral triptans (serotonin 5-HT (1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001 358 ( 9294 1668 75.
6. Visser WH de Vriend RH Jaspers NHWM Ferrari MD. Sumatriptan - nonresponders: a survey in 366 migraine patients. Headache 1996 36 : 471 5.
7. Dahlof CG. How does sumatriptan perform in clinical practice? Cephalalgia 1995 15 ( Suppl. 15 21 8.
8. Visser WH de Vriend RH Jaspers NHWM Ferrari MD. Sumatriptan in clinical practice: a 2-year review of 453 migraine patients. Neurology 1996 47 : 46 51.
9. Gjsman H Kramer MS Sargent J Tuchman M Matzura-Wolfe D Polis A et al. Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine. Cephalalgia 1997 17 : 647 51.
10. Ferrari MD Loder E McCarroll KA Lines CR. Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials. Cephalalgia 2001 21 : 129 36.
11. Tfelt-Hansen P Teall J Rodriguez F Giacovazzo M Paz J Malbecq W et al. Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Headache 1998 38 : 748 55.
12. Peroutka SJ. Beyond monotherapy: rational polytherapy in migraine. Headache 1998 38 : 18 22.
13. Krymchantowski AV. Acute treatment of migraine. Breaking the paradigm of monotherapy. BMC Neurol 2004 28 : 4.
14. Schulman EA Dermott KF. Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs. Headache 2003 43 : 729 33.
15. Moro E Crema F De Ponti F Frigo G. Triptans and gastric accommodation: pharmacological and therapeutic aspects. Dig Liver Dis 2004 36 : 85 92.
16. Lychkova AE. Serotoninergic nervous system in intact heart and abdominal organs. Bull Exp Biol Med 2004 138 : 127 30.
17. Mathew NT Kailasam J Meadors L. Early treatment of migraine with rizatriptan: a placebo-controlled study. Headache 2004 44 : 669 73.
18. Burstein R Jakubowski M. Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol 2004 55 : 27 36.
19. Taniyama K Sano I Nakayama S Matsuyama S Takeda K Yoshihara C Tanaka C. Dual effect of trimebutine on contractility of the guinea pig ileum via opioid receptors. Gastroenterology 1991 101 : 1579 87.
20. Uchida M Iwata T Takagi S Sugiyama Y Ishitani K Honda H Sakai Y. Effect of trimebutine maleate on the contractile response of the isolated ileum from diabetic rats. Gen Pharmac 1994 25 : 505 8.
21. Luttecke K. A trial of trimebutine in spastic colon. J Int Med Res 1978 6 : 86 8.
22. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia 2004 24 : 1 160.
23. Fielding JF. Double blind trial of trimebutine in the irritable bowel syndrome. Ir Med J 1980 73 : 377 9.
24. Poynard T Naveau S Mory B Chaput JC. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1994 8 : 499 602.
25. MacGregor EA Wilkinson M Bancroft K. Domperidone plus paracetamol in the treatment of migraine. Cephalalgia 1993 13 : 124 7.
26. Krymchantowski AV. Naproxen sodium decreases migraine recurrence when administered with sumatriptan. Arq Neuropsiquiatr 2000 58 ( 2-B 428 30.
27. Krymchantowski AV Barbosa JS. Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study. Cephalalgia 2002 22 : 309 12.
28. Krymchantowski AV Bigal ME. Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine. BMC Neurol 2004 28 : 10.
29. Dahlof CGH Hargreaves RJ. Pathophysiology and pharmacology of migraine. Is there a place for antiemetics in future treatment strategies? Cephalalgia 1998 18 : 593 604.
30. Delvaux M Wingate D. Trimebutine: mechanism of action, effects on gastrointestinal function and clinical results. J Intern Med Res 1997 25 : 225 46.